reddit.com· r/HerpesCureResearch · Reddit·· 8 days agoPickScore65
US FDA approves Asahi Kasei's drug for persistent herpes infections
In brief
The FDA approved Asahi Kasei's pritelivir (Hovilpri), a helicase-primase inhibitor, on 2026-10-09 for refractory HSV mucosal infections in immunocompromised adults, making it the first HSV drug with a new mechanism in nearly 30 years. Approval rests on the Phase 3 PRIOH-1 trial. Reddit users criticized accessibility, with one estimating roughly $26,667 per person for a 42-day course based on projected revenue of $400 million across 15,000 immunocompromised patients; no official price was given.
Why it matters
First new-mechanism HSV drug approval in nearly 30 years, with community-disputed cost estimates.
Source: reddit.com